IL10 and breast cancer: Our results showed that pretreatment with varying doses of BC, particularly the moderate dose, led to a pronounced downregulation of the three pro-inflammatory cytokines with a significant upregulation of IL-10, implying BC’s potential to ameliorate KP-induced inflammation in the rabbit liver.